期刊
ANNALS OF EMERGENCY MEDICINE
卷 78, 期 1, 页码 102-108出版社
MOSBY-ELSEVIER
DOI: 10.1016/j.annemergmed.2021.01.017
关键词
-
资金
- Health Resources and Services Administration [6 GA1RH334840102]
- Advance-CTR Mentored Research Award [U54GM115677]
Buprenorphine treatment greatly reduces mortality among individuals with opioid use disorder, and EMS professionals can play a critical role in bridging the treatment gap to provide better care for those who experience opioid overdoses.
Treatment with buprenorphine significantly reduces both all-cause and overdose mortality among individuals with opioid use disorder. Offering buprenorphine treatment to individuals who experience a nonfatal opioid overdose represents an opportunity to reduce opioid overdose fatalities. Although some emergency departments (EDs) initiate buprenorphine treatment, many individuals who experience an overdose either refuse transport to the ED or are transported to an ED that does not offer buprenorphine. Emergency medical services (EMS) professionals can help address this treatment gap. In this Concepts article, we describe the federal legal landscape that governs the ability of EMS professionals to administer buprenorphine treatment, and discuss state and local regulatory considerations relevant to this promising and emerging practice.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据